Investigator
Kevin C O'connor
YALE UNIVERSITY · funded by NIAID, NINDS
- Companies
- 1
- Grants
- 5
- Non-dilutive funding
- $1.5M
- First award
- Aug 1, 2015
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Jun 9, 2026.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- HEALTHPARTNERS INSTITUTE100momentum
OncologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R21
Heterogeneity in autoimmune myasthenia gravis: classifying disease variants by unique immune mechanisms to inform personalized therapeutic strategies
$252kJun 9, 2026NIAIDYALE UNIVERSITYNIH RePORTER · 11349770 (opens the source filing in a new tab)
- R21
Identifying new antigens in human autoantibody-mediated disease
$251kSep 2, 2025NIAIDYALE UNIVERSITYNIH RePORTER · 11215108 (opens the source filing in a new tab)
- U54
Project 3
$145kSep 1, 2019NINDSGEORGE WASHINGTON UNIVERSITYNIH RePORTER · 11171997 (opens the source filing in a new tab)
- R01
Mechanisms of autoimmunity in myasthenia gravis
$335kNov 4, 2015NIAIDYALE UNIVERSITYNIH RePORTER · 11127030 (opens the source filing in a new tab)
- R01
Mechanisms of autoimmunity in myasthenia gravis
$477kAug 1, 2015NIAIDYALE UNIVERSITYNIH RePORTER · 10904878 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources